Skip to main content
. 2016 Jul 8;7(32):52032–52044. doi: 10.18632/oncotarget.10496

Table 3. Patient samples enrolled for ELISA and IHC-P detection.

Serum Tissue
Healthy n (%) CRC n (%) Normal n (%) CRC tissue n (%)
Gender Female 17 (49) 13 (43) 4 (40) 14 (43)
Male 18 (51) 17 (57) 6 (60) 19 (57)
Age 36-59 15 (43) 14 (47) 5 (50) 16 (48)
60-69 10 (29) 10 (33) 3 (30) 12 (36)
>69 10 (29) 6 (20) 2 (20) 5 (16)
Stage I - 4 (13) - 5 (15)
II - 14 (47) - 14 (43)
III - 7 (23) - 9 (27)
IV - 5 (17) - 5 (15)
Total 35 30 10 33